InVita Health & Wellness

InVita Health & Wellness operates in La Vista, Nebraska, under the clinical direction of Angelina Giles, DNP, APRN, FNP-BC and Kris Epps-Martinez, APRN, FNP-BC, both board-certified Family Nurse Practitioners with expertise in metabolic health and hormone regulation. The clinic serves patients across Nebraska, Iowa, and Florida through a hybrid model that combines in-person consultations at their La Vista location with comprehensive telehealth services, allowing patients to access evidence-based medical weight loss and hormone optimization regardless of geographic constraints. This dual-access approach has proven particularly effective for patients managing chronic metabolic conditions who require consistent provider communication and protocol adjustments without the burden of frequent travel.

The clinic's medical weight loss programs center on GLP-1 receptor agonist peptides, specifically liraglutide and semaglutide, which both Giles and Epps-Martinez prescribe as part of structured protocols that include baseline metabolic panels, body composition analysis, and cardiovascular risk assessment. Patients beginning semaglutide therapy typically start at 0.25 mg weekly with titration schedules individualized based on tolerance and response metrics tracked through the clinic's patient portal. Liraglutide protocols follow similar precision, with daily dosing adjusted according to glycemic control markers and weight loss velocity. These peptide interventions are integrated with nutritional counseling that addresses macronutrient timing, insulin sensitivity optimization, and sustainable dietary patterns rather than restrictive calorie models. The clinic also provides hormone replacement therapy for both men and women, addressing thyroid dysfunction, estrogen/progesterone imbalances, and testosterone deficiency through bioidentical hormone protocols tailored to symptom profiles and laboratory findings.

Both Giles and Epps-Martinez bring clinical backgrounds in family medicine that inform their approach to weight management as a component of overall metabolic health rather than an isolated aesthetic goal. Their protocols account for comorbidities including hypertension, prediabetes, and polycystic ovary syndrome, with treatment plans designed to address root dysfunction rather than symptom suppression. Patients with elevated blood pressure undergo cardiovascular monitoring throughout GLP-1 therapy, with medication adjustments coordinated between weight loss protocols and antihypertensive management. The providers conduct comprehensive intake assessments that explore medication history, previous weight loss attempts, stress physiology, and sleep quality—factors that directly influence peptide therapy outcomes and long-term metabolic health.

Patients initiating care at InVita Health & Wellness complete detailed health questionnaires and laboratory panels before their first consultation, ensuring that Giles or Epps-Martinez can deliver specific recommendations during the initial visit rather than generic treatment overviews. Follow-up schedules vary by protocol complexity, with most semaglutide patients checking in biweekly during titration phases and monthly once stable dosing is established. The clinic's telehealth platform supports secure messaging for questions between appointments, a feature patients frequently reference when discussing the accessibility of their care team. For those seeking medical aesthetics, the La Vista office provides neuromodulator treatments and dermal fillers administered by the nurse practitioners, often coordinated with hormone optimization programs for patients addressing age-related changes in skin quality and facial volume.

InVita Health & Wellness distinguishes itself through the clinical depth both providers bring to metabolic medicine and their willingness to manage complex cases involving multiple hormonal imbalances or medication interactions. The clinic does not operate on a one-size-fits-all model; patients with thyroid antibodies receive different GLP-1 titration schedules than those with isolated insulin resistance, and women in perimenopause follow hormone protocols distinct from those in surgical menopause. This specificity, combined with the flexibility of telehealth access across three states and the consistent availability of both Giles and Epps-Martinez for clinical questions, has established the practice as a resource for patients seeking medically supervised weight loss and hormone therapy grounded in individualized assessment rather than protocol templates.